1. Home
  2. WPC vs BBIO Comparison

WPC vs BBIO Comparison

Compare WPC & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W. P. Carey Inc. REIT

WPC

W. P. Carey Inc. REIT

N/A

Current Price

$64.43

Market Cap

14.5B

Sector

Real Estate

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$74.59

Market Cap

13.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WPC
BBIO
Founded
1973
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
13.3B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
WPC
BBIO
Price
$64.43
$74.59
Analyst Decision
Buy
Buy
Analyst Count
15
22
Target Price
$74.07
★ $106.85
AVG Volume (30 Days)
1.7M
★ 2.7M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
★ 5.88%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.33
N/A
Revenue
★ $1,716,485,000.00
$502,076,000.00
Revenue This Year
$8.61
$118.43
Revenue Next Year
$7.24
$51.86
P/E Ratio
$48.56
★ N/A
Revenue Growth
8.43
★ 126.26
52 Week Low
$62.19
$60.55
52 Week High
$77.22
$93.42

Technical Indicators

Market Signals
Indicator
WPC
BBIO
Relative Strength Index (RSI) 47.15 73.24
Support Level $62.24 $63.16
Resistance Level $65.45 $85.42
Average True Range (ATR) 1.28 2.06
MACD 0.25 1.26
Stochastic Oscillator 57.40 98.56

Price Performance

Historical Comparison
WPC
BBIO

About WPC W. P. Carey Inc. REIT

W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: